Radar · Healthcare in Cambridge
Best Healthcare Companies in Cambridge, United States
The 125 best Healthcare companies in Cambridge, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Broad Institute.
By Riya SenguptaFinancials
125companies tracked
$4.1Bdisclosed funding
0unicorns
56have raised
Ranked: Best Healthcare companies in Cambridge
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Broad Institute R&D focused on development of drugs | $762M | 5 mo ago | Funding Raised | 2,033 2,033 → 3,206 (+58%) | — | — | 1 expansion |
| 2 | EQRx Manufacturer of medicines | $700M | 65 mo ago | Acquired | 363 | — | — | — |
| 3 | Laronde Developer of RNA therapeutics | $440M | 57 mo ago | Series B | 116 | — | — | — |
| 4 | Senda Biosciences Manufacturer of drugs for multiple therapeutic areas | $266M | 46 mo ago | Series C | 102 | Fabrice Chouraqui CEO | 56 patents Ionizable lipid nanoparticles for mRNA delivery and AHR antagonist small‑molecule therapeutics | — |
| 5 | VIZGEN Developer of solutions for healthcare data analytics and single-cell gene expression profiling | $188M | 5 mo ago | Series E | 201 | Xiaowei Zhuang Co-Founder | 12 patents Spatial nucleic acid imaging and multiplexed FISH probe anchoring technologies | 3 launchs · 2 awards |
| 6 | Acceleron Pharma Developer of protein therapeutics to treat cancer and rare blood disorders | $138M | 109 mo ago | Acquired | 312 | — | 1,929 patents Therapeutic protein biologics targeting pulmonary hypertension and systemic sclerosis pathways | — |
| 7 | AWH Provider of cannabis plants and products services | $135M | 35 mo ago | Public | 3,307 | Frank Perullo Co-Founder and Director | — | — |
| 8 | AXONIS Therapeutics Provider of drug discovery services | $124M | 16 mo ago | Series A | 14 | Joanna Stanicka Co-Founder & CEO | — | — |
| 9 | Hydra Biosciences Develops ion-channel based drugs for diabetic neuropathy, allergic asthma and pulmonary diseases | $112M | 135 mo ago | Series E | 12 | — | 397 patents Small-molecule TRPC6/TRPC5 ion channel inhibitors for therapeutic modulation. | — |
| 10 | Satellite Bio Developer of proprietary implantable satellite organs | $110M | 51 mo ago | Series A | 21 21 → 24 (+14%) | Arnav Chhabra Co-Founder | — | — |
| 11 | Exo Therapeutics Manufacturer of drugs for multiple therapeutic areas | $103M | 56 mo ago | Series B | 15 15 → 16 (+7%) | Alan Saghatelian Co-Founder | — | — |
| 12 | EdenRoc R&D company focused on manufacturing of drugs for multiple therapeutic areas | $100M | 19 mo ago | Series D | 12 | — | — | — |
| 13 | Matchpoint Therapeutics Provider of small molecular medicine development and analytics services | $100M | 44 mo ago | Series A | 27 27 → 32 (+19%) | Tinghu Zhang Co-Founder | — | — |
| 14 | Rectify Pharma Manufacturer of drugs for multiple therapeutic purposes | $100M | 56 mo ago | Series A | 31 | Jonathan Moore Founder | — | — |
| 15 | Navitor Developing therapeutics for age related, rare and genetic diseases by targeting the central regulator of… | $99M | 73 mo ago | Series C | 15 | — | 8 patents Ink-jet/ink-roller self-inking marking devices and adjustable card reel clip mechanisms | — |
| 16 | Anji Pharmaceuticals Developer of peptides for treatment of hypercholesterolemia | $70M | 56 mo ago | Series B | 12 | — | — | — |
| 17 | SURGE Provider of intraoperative immunotherapy services for cancer patients | $58M | 36 mo ago | Series B | 6 | Michael Goldberg Founder & CEO | — | — |
| 18 | SciFluor Innovative therapeutics for ophthalmology, fibrosis, and neurology using fluorine chemistry | $50M | 61 mo ago | Series B | 2 | — | — | — |
| 19 | Momenta Developer of novel therapies for rare immune-mediated diseases | $40M | 267 mo ago | Acquired | 134 | Christoph Westphal Co-Founder | — | — |
| 20 | Cartwheel Mental health partner for K-12 school districts offering personalized support by licensed clinicians 57Funding top 25%Tech top 33%Growth top 35%Talent top 38% All 6 signals ▾Fundingtop 25% Techtop 33% Growthtop 35% Talenttop 38% Marketbottom 28% Globalbottom 25% Funding: Raised $35.2M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Tech: 32 technologies across 6/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 57/100 | $35M | 10 mo ago | Series C | — | Daniel Tartakovsky Co-Founder | — | 2 partnerships |
| 21 | Anchor Therapeutics Targeted small peptide therapeutics for metabolic and cardiovascular diseases. | $30M | 190 mo ago | Deadpooled | 3 | — | — | — |
| 22 | Volta Labs Laboratory focused on biotechnology & molecule research services | $25M | 29 mo ago | Series A | 41 | Udayan Umapathi Co-Founder & CEO | — | 1 partnership |
| 23 | Neutrolis R&D company focused on manufacturing of drugs for multiple therapeutic areas | $23M | 15 mo ago | Series B | 9 | Abdul Hakkim Co-Founder | 91 patents Engineered DNase enzymes for therapeutic and industrial nucleic acid degradation applications | — |
| 24 | Padlock Therapeutics R&D company focused on manufacturing of drugs for multiple therapeutic areas | $23M | 138 mo ago | Series A | 5 | — | — | — |
| 25 | Goodpath Provider of healthcare plans for back pain, sleep, and IBS issues 55Funding top 34%Growth top 35%Tech top 35%Global top 45% All 8 signals ▾Fundingtop 34% Growthtop 35% Techtop 35% Globaltop 45% Talentbottom 49% Productbottom 48% Marketbottom 37% Customersbottom 5% Funding: Raised $22.0M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 10 mo ago | Series A | 44 | Bill Gianoukos Founder & CEO | — | 3 job openings |
| 26 | Xenetic Biopharmaceutical company advancing immune-oncology technologies for high-value cancer indications | $19M | 44 mo ago | Public | 4 | — | — | — |
| 27 | Reveal Pharmaceuticals Gadolinium-free MRI contrast agents for safer medical imaging and diagnostics | $16M | 36 mo ago | Funding Raised | 8 | Peter Caravan Co-Founder | — | — |
| 28 | Droplet Biosciences Provider of lymph liquid biopsy for cancer recurrence prediction | $16M | 30 mo ago | Seed | 14 | — | 54 patents Liquid biopsy technologies for postoperative cancer monitoring and minimal residual disease detection | — |
| 29 | Quantori Provider of IT service suite solutions | $15M | 47 mo ago | Seed | 519 | Richard Golob CEO | 4 patents AI-driven multi‑reference conformational modeling for de‑novo pharmaceutical compound design | 1 award |
| 30 | DoubleRainbow Biosciences Developer of sustainable therapeutics and nutraceuticals using natural product manufacturing | $15M | 67 mo ago | Series B | 15 | Tian Xu Co-Founder | — | — |
| 31 | KalVista Therapies for hereditary angioedema and diabetic macular edema based on small molecule plasma kallikrein… | $13M | 131 mo ago | Acquired | 118 118 → 273 (+131%) | — | — | — |
| 32 | Cequent Pharmaceuticals Pioneering RNAi therapeutics for diverse diseases, including cancer and inflammatory conditions | $12M | 199 mo ago | Acquired | — | Johannes Fruehauf ex-President | — | — |
| 33 | 2Pi Optics Manufacturer of optical metasurfaces 22Funding top 29%Talent bottom 45%Global bottom 29%Market bottom 25% All 4 signals ▾Fundingtop 29% Talentbottom 45% Globalbottom 29% Marketbottom 25% Funding: Raised $12.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 22/100 | $12M | 8 mo ago | Series B | 7 | Mikhail Shalaginov Co-Founder & CSO | — | — |
| 34 | Lytica Therapeutics Developer of therapeutic drugs | $12M | 15 mo ago | Series A | 10 | Jim LaTorre CEO | — | — |
| 35 | PROXIMITY THERAPEUTICS Provider of biotechnology development services | $11M | 41 mo ago | Series B | — | Guillermo Elias CEO | — | — |
| 36 | STRM.BIO R&D company focused on manufacturing gene therapy diagnostic tests for multiple therapeutic areas | $10M | 5 mo ago | Seed | 23 | Jonathan Thon Founder | — | 1 launch |
| 37 | Kano Therapeutics Developer of circular single-stranded DNA for targeted gene-length DNA correction | $7M | 25 mo ago | Seed | 9 | Mark Bathe Co-Founder | — | — |
| 38 | Omnipulse Biosciences Distributor of pharmaceutical products | $7M | 30 mo ago | Series A | — | Ana Jaklenec Founder | — | — |
| 39 | Permeon Biologics Develops a panel of human proteins | $6M | 173 mo ago | Deadpooled | — | John Ripple ex-CEO | — | — |
| 40 | Leadart Biotechnologies Provider of drug target discovery platform and probe library | $6M | 41 mo ago | Seed | 60 | Yufeng Zhao Co-Founder | — | — |
| 41 | Eulysis Provider of diabetes management and lifestyle modification services | $5M | 132 mo ago | Series A | 3 | — | — | — |
| 42 | Seaspire Skincare Manufacturer of skincare cosmeceutical products | $4M | 49 mo ago | Seed | 5 | Camille Martin Co-Founder & CEO | — | — |
| 43 | Expansion Technologies Innovating brain research through advanced microscopy and simulation technologies | $4M | 16 mo ago | Series A | 2 | Ed Boyden Co-Founder | 2 patents Pipe/tube expansion devices for mechanical deformation and fabrication processes. | — |
| 44 | Rural Health Development Provider of management and consulting services for rural healthcare facilities | $2M | 13 mo ago | Funding Raised | 31 | — | — | — |
| 45 | MedPanel Global healthcare market research partner providing insights for biopharma and medtech | $2M | 137 mo ago | Acquired | 30 | Janet Bernard CEO & President | — | — |
| 46 | Cytel Provider of data analysis and statistical solutions for the life sciences industry | $2M | 103 mo ago | Acquired | 509 | Cyrus Mehta Co-Founder & President | 43 patents Clinical trial design and analytics platform integrating systematic literature review | — |
| 47 | Piper Therapeutics Pre-clinical drug discovery company focused on higher order pathways that govern immune and inflammatory… | $1M | 121 mo ago | Deadpooled | — | Russ Wilcox CEO | — | — |
| 48 | Pearl Bio Developer of biomaterial platform using synthetic biology for diverse chemistry applications | $844K | 24 mo ago | Funding Raised | 9 | Amy Cayne Schwartz Co-Founder | — | — |
| 49 | Stratagenbio Provider of a tool for quantitative biomarker assessment and clinical decision making | $800K | 28 mo ago | Seed | 4 | Gregory Ekchian Co-Founder & CEO | — | — |
| 50 | Artificial Axon Labs Research laboratory focused on developing medicines for neurodegenerative diseases | $506K | 21 mo ago | Funding Raised | — | Kavin Kowsari Co-Founder | — | — |
Top 12 Healthcare companies in Cambridge
#1
Funding Raised · Cambridge, Massachusetts · founded 2003 · 2033 employees$762.1Mraised▾
Funding Raised · Cambridge, Massachusetts · founded 2003 · 2033 employees
R&D focused on development of drugs
LinkedIn Pulse recent public activity · Jul 2026
Audience: 168k LinkedIn followers — 39.8% of this cohort's audience
Activity: 1 expansions announced in 12 mo
Funding rounds
- Dec 2025Grant (prize money)$1.6M
- Dec 2025Grant (prize money)$16.6M
- Dec 2025Grant (prize money)$158K
- Dec 2025Grant (prize money)$6.9M
Investors
Europa, HHS, United States Department of Agriculture, National Science Foundation, Military Health
Tech stack
Acquia Cloud PlatformAcquia Cloud Platform CdnAddtoanyAmazon S3Amazon Web ServicesApache Http Server
#2
Series E · Cambridge, Massachusetts · founded 2019 · 201 employees$187.7Mraised▾
Series E · Cambridge, Massachusetts · founded 2019 · 201 employees
Developer of solutions for healthcare data analytics and single-cell gene expression profiling
LinkedIn Pulse recent public activity · Jul 2026
Audience: 19k LinkedIn followers — 4.5% of this cohort's audience
Activity: 3 product launches · 2 awards announced in 12 mo
Funding rounds
- Dec 2025Series E$48M
- Oct 2025Conventional Debt$3.5M
- Mar 2024Series C—
- Apr 2022Series C$85.2M
Founders & team
Investors
Arch Venture Partners, Northpond Ventures, Novalis LifeSciences, Tao Capital Partners, Pura Vida Investments, Blue Water Life Science Advisors
Tech stack
Amazon S3Amazon Web ServicesAosApple Icloud MailCdnjsCloudflare
#3
Seed · Cambridge, Massachusetts · founded 2019 · 23 employees$9.8Mraised▾
Seed · Cambridge, Massachusetts · founded 2019 · 23 employees
R&D company focused on manufacturing gene therapy diagnostic tests for multiple therapeutic areas
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
- Jan 2026Seed$8M
- Nov 2025Grant (prize money)$1.8M
Founders & team
Investors
Recordati, Boehringer Ingelheim Venture Fund, Delos Capital Partners, Bluebay Capital, HHS, Calm Ventures
#4
Series A · Cambridge, Massachusetts · founded 2011 · 14 employees$124Mraised▾
Series A · Cambridge, Massachusetts · founded 2011 · 14 employees
Provider of drug discovery services
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Senior/Principal Scientist, Medicinal Chemistry
Activity: 1 awards announced in 12 mo
Funding rounds
- Feb 2025Grant (prize money)$129.3K
- Oct 2024Series A$115M
- Sep 2024Grant (prize money)$323K
- Jun 2023Grant (prize money)$299.8K
Founders & team
Investors
Alexandria, R3, Civilization Ventures, BoxOne Ventures, Spinal Research, Christopher & Dana Reeve Foundation
Tech stack
AstraCloudflareCloudflare Bot ManagementContact Form 7Core-JsElementor
#5
Series C · Cambridge, Massachusetts · founded 2022$35.2Mraised▾
Series C · Cambridge, Massachusetts · founded 2022
Cartwheel Care partners with K-12 school districts to deliver personalized mental health support through licensed clinicians with no waitlists.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 25%Tech
top 33%Growth
top 35%Talent
top 38%Market
bottom 28%Global
bottom 25%Funding: Raised $35.2M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series C (Aug 2025)
Tech: 32 technologies across 6/8 capability areas · Cloud: Cloudflare · Devops: Nginx
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 18k LinkedIn followers — 4.4% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Cartwheel) announced in 12 mo
Funding rounds
- Aug 2025Series C$35.2M
Founders & team
Tech stack
6SenseCart FunctionalityChart.JsCloudflareCloudflare Bot ManagementCore-Js
#6
Series B · Cambridge, Massachusetts · founded 2021 · 7 employees$12Mraised▾
Series B · Cambridge, Massachusetts · founded 2021 · 7 employees
Developer of metasurface flat optics technology designed to overcome fundamental limitations of the traditional optical system. The company's technology uses ultra-compact 3D sensors and advanced meta-optics technology, enabling clients to deliver flat optics services with proper performance and reduced cost.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 29%Talent
bottom 45%Global
bottom 29%Market
bottom 25%Funding: Raised $12.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) · Last round Series B (Oct 2025)
Talent: 1 named leader on record
Global: Single-market focus (United States)
Audience (LinkedIn): 541 LinkedIn followers
Funding rounds
- Oct 2025Series B$11.7M
- Dec 2022Grant (prize money)$256K
Founders & team
Investors
National Science Foundation, Safar Partners
#7
Series A · Cambridge, Massachusetts · founded 2018 · 44 employees$22Mraised▾
Series A · Cambridge, Massachusetts · founded 2018 · 44 employees
Provider of healthcare plans for back pain, sleep, and IBS issues
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 34%Growth
top 35%Tech
top 35%Global
top 45%Talent
bottom 49%Product
bottom 48%Funding: Raised $22.0M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) · Last round Series A (Jul 2025)
Growth: Fresh capital in last 24 mo
Tech: 31 technologies across 5/8 capability areas · Cloud: Amazon Alb, Amazon Web Services · Observability: Sentry
Audience (LinkedIn): 15k LinkedIn followers — 3.5% of this cohort's audience
Hiring (LinkedIn): 3 hiring posts in 12 mo (public) · momentum +3 · hiring: Clinical Heath Coach, Enterprise Account Executive
Funding rounds
- Jul 2025Series A$18M
- Apr 2020Seed$4M
Founders & team
Investors
Indicator Ventures, Switch, Blindspot Ventures, Global Founders Capital, MassMutual Ventures, Healthy Ventures
Tech stack
Amazon AlbAmazon Web ServicesAmplitudeContentfulCore-JsFirebase
#8
Series D · Cambridge, Massachusetts · founded 2016 · 12 employees$100.1Mraised▾
Series D · Cambridge, Massachusetts · founded 2016 · 12 employees
Operator of a biotechnology company intended to cultivate life sciences start-up companies. The company specializes in enabling the translation of top-tier academic and government science into technologies that provide novel and cutting-edge research tools, diagnostics and pharmaceuticals, thereby helping clients to address multiple biotech and healthcare markets.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Nov 2024Series D$2.8M
- Jun 2022Series D$64.2M
- May 2021Series C$35.9M
Investors
FOD Capital
#9
Series B · Cambridge, Massachusetts · founded 2017 · 9 employees$23.1Mraised▾
Series B · Cambridge, Massachusetts · founded 2017 · 9 employees
R&D company focused on manufacturing of drugs for multiple therapeutic areas
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- Feb 2025Series B$965K
- Dec 2021Series B$23.1M
- May 2020Grant (prize money)$251.7K
Founders & team
Investors
HHS, Prefix Capital, PBJ Capital, Morningside
Tech stack
CloudflareHstsHttp/3JqueryJquery CdnMicrosoft 365
#10
Series A · Cambridge, Massachusetts · founded 2019 · 10 employees$11.8Mraised▾
Series A · Cambridge, Massachusetts · founded 2019 · 10 employees
Developer of therapeutic drugs
Funding rounds
- Feb 2025Conventional Debt$6M
- Jul 2024Series A$1.8M
- Feb 2024Series A$4.1M
- Feb 2020Grant (prize money)—
Founders & team
Investors
CARB-X
#11
Funding Raised · Cambridge, Nebraska · founded 1990 · 31 employees$2.5Mraised▾
Funding Raised · Cambridge, Nebraska · founded 1990 · 31 employees
Provider of management and consulting services for rural healthcare facilities. It assists independent healthcare facilities with management services to operate successfully. The company offers consulting services and full management contracts. It also provides medical billing and consulting through a sister company. The company offers in-services for healthcare facility employees and assists with HIPAA regulation compliance.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 308 LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum -2 · hiring: Business & Project Support Specialist
Funding rounds
- May 2025Grant (prize money)$750K
- 2023Grant (prize money)$100K
- 2022Grant (prize money)$250K
- 2021Grant (prize money)$250K
Investors
HRSA, HHS
Tech stack
WordpressMysqlPhpGoogle MapsPhoto GalleryYoast Seo
#12
Series A · Cambridge, Massachusetts · founded 2015 · 2 employees$3.5Mraised▾
Series A · Cambridge, Massachusetts · founded 2015 · 2 employees
Innovating brain research through advanced microscopy and simulation technologies. The company pioneers computer simulations of the human brain, leveraging connectivity and molecular insights to revolutionize AI development, brain disease treatment, and our understanding of the human condition. They achieve this through novel tools, including expansion microscopy, optogenetics, and high-speed brain activity imaging. Expansion microscopy, a core invention, enables nanoprecise imaging of large-scale brain tissues with molecular information. This technology permeates brain tissue and physically expands it, allowing for detailed analysis. The company's work has potential social impact in healthcare and technology, pushing the boundaries of neuroscience and offering new avenues for research and discovery.
Funding rounds
- Feb 2025Grant (prize money)$500K
- Sep 2022Grant (prize money)$500K
- Nov 2017Series A$1.5M
- Feb 2016Series A$2M
Founders & team
Investors
HHS
Funding & investor landscape
$4.1Btotal disclosed funding
57companies funded
257disclosed rounds
0rounds last 90 days
Most active investors
Atlas Venture5 rounds
Notable founders
Xiaowei Zhuang
Co-Founder · VIZGEN
George Emanuel
Co-Founder · VIZGEN
Jonathan Thon
Founder · STRM.BIO
Joanna Stanicka
Co-Founder & CEO · AXONIS Therapeutics
Bob Yant
Founder · AXONIS Therapeutics
Daniel Tartakovsky
Co-Founder · Cartwheel
Joe English
Co-Founder & CEO · Cartwheel
Mikhail Shalaginov
Co-Founder & CSO · 2Pi Optics
Bill Gianoukos
Founder & CEO · Goodpath
Abdul Hakkim
Co-Founder · Neutrolis
Jim LaTorre
CEO · Lytica Therapeutics
Ed Boyden
Co-Founder · Expansion Technologies
Prism market signals · United States · country-scoped Prism corpus, 13,358,462 docs
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Healthcare companies are there in Cambridge, United States?
Radar tracks 125 indexable Healthcare companies headquartered in Cambridge, United States that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Cambridge, United States?
The Healthcare companies in Cambridge, United States on this list have raised a combined $4.1B in disclosed equity funding across 57 funded companies.
Which is the highest-funded Healthcare company in Cambridge, United States?
Broad Institute is the highest-funded Healthcare company in Cambridge, United States, with $762.1M in disclosed equity funding.
How many Healthcare companies in Cambridge, United States are funded?
57 of the 125 Healthcare companies in Cambridge, United States on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Cambridge, United States?
None of the Healthcare companies in Cambridge, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Cambridge, United States Healthcare companies?
The most active investors in Cambridge, United States Healthcare companies on this list include HHS, MassChallenge, Polaris Partners, Atlas Venture, Flagship Pioneering.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.